Quantifying Withanolides in Plasma: Pharmacokinetic Studies and Analytical Methods.

Area of Science:

• Pharmacology and Pharmacokinetics
• Phytochemistry
• Analytical Chemistry

Background:

• Withania somnifera (ashwagandha) is an Ayurvedic herb recognized for stress and insomnia relief.
• Withanolides, steroidal lactones, are the primary bioactive compounds investigated in ashwagandha.
• Understanding the plasma presence and pharmacokinetics of withanolides is crucial for their therapeutic application.

Purpose of the Study:

• To review current knowledge on the plasma pharmacokinetics of withanolides from ashwagandha.
• To summarize analytical methods used for detecting withanolides in plasma.
• To consolidate findings from human and animal studies on withanolide absorption and metabolism.

Main Methods:

• Systematic review of twenty studies (16 animal, 4 human).
• Analysis of studies quantifying isolated withanolides or ashwagandha products in plasma.
• Commonly employed analytical technique: reversed-phase liquid chromatography coupled to mass spectrometry (LC-MS).

Main Results:

• Plasma concentrations of withanolides varied significantly based on the specific compound, dose, and administration route.
• Rodent studies reported Cmax ranges for six withanolides (5.6-8410 ng/mL).
• Human studies detailed pharmacokinetic parameters for four withanolides, with Cmax ranging from 0.1-49.5 ng/mL.

Conclusions:

• Withanolides from ashwagandha are detectable in plasma following administration.
• Significant variability exists in the pharmacokinetic profiles of different withanolides.
• Further research is needed to fully elucidate the in vivo behavior of these compounds.